Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 642 for your search:
Drug:  aldesleukin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CWRU-CHIR-1899, CHIR-MA-99-01, CWRU-010002, NCI-G00-1875, NCT00006864

2.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: IRB00024759, R01MH071580, DATR A3-NSS, NCT00352885

3.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EPC2008-02, NCT01347996

4.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A6181203, DARENCA STUDY 2, NCT01339962

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AIS-1061-9320, NCI-V95-0689

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: CNR-9505, EU-95023

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor:
Protocol IDs: FRE-FNCLCC-95009, EU-96026

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: NCI-C87-0001, AECM-8706153, CHNMC-COH-7077, CMGH-8756-S-87A, CWRCC-0987188, DUMC-7988710, FCCC-88982, IDB-MGC-RENAL/RAND, JHOC-87092507, MDA-DM-87059, UAC-345, UCCRC-4998, UPCC-1887, UUMC-2056, VRCC-CHRMS-8831, WSU-C-70387, YALE-HIC-4454, C87-0001

9.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: NCI-C87-0002, AECM-8706152, CHNMC-COH-7075, CMGH-8755-S-87A, CWRCC-0787137, DUMC-7958710, IDB-MGC-MEL/RAND, JHOC-87092508, MDA-DM-87056, UAC-343, UCCRC-4985, UKMC-8800110, UPCC-1687, UUMC-2055, VRCC-CHRMS-8832, WSU-C-70487, YALE-HIC-4455, C87-0002

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: UCCRC-4973A, NCI-V87-0310

11.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: UCCRC-4973B, NCI-V87-0311

12.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: UCCRC-4973C, NCI-V87-0312

13.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 to 70
Sponsor:
Protocol IDs: NYH-1088-350CRC, NCI-V88-0417

14.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AHOD0121, CDR0000330135, COG-AHOD0121, NCT00070187

15.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IL2NHL03, UCLA-0302013, CHIR-IL2NHL03-A01, NCT00045877

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: not over 55
Sponsor:
Protocol IDs: FHCRC-701.1, NCI-V94-0401

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 to 60
Sponsor: NCI
Protocol IDs: SWOG-9328, E-S9328

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: PCI-9430, NCI-V94-0493

19.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: 75 and under
Sponsor: Other
Protocol IDs: CNR-9506, EU-95024, NCT00002702

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 10 to 70
Sponsor: NCI, Other
Protocol IDs: ID95-196, P30CA016672, MDA-ID-95196, MDA-DM-95196, NCI-G96-1089, CDR0000065188, NCT00002882

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 25
Sponsor: Other
Protocol IDs: CDR0000065406, RPCI-DS-96-48, NCI-G97-1152, NCT00002945

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: MAXIM-US-M01, NCI-V98-1382

24.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066161, E-2Z96, NCI-P98-0130, NCT00003266

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: J9726 CDR0000066427, P30CA006973, P01CA015396, JHOC-97080106, JHOC-9726, NCI-V98-1453, NCT00003414
1     
New Search